# Genistein, Equol, Cognitive Function and Mood: Twelve-week. (GECFAMc)

> **NCT07742501** · NA · COMPLETED · sponsor: **University of Reading** · enrollment: 51 (actual)

## Conditions studied

- Cognition
- Mood

## Interventions

- **DIETARY_SUPPLEMENT:** Equol
- **DIETARY_SUPPLEMENT:** Genistein
- **DIETARY_SUPPLEMENT:** Maltodextrin

## Key facts

- **NCT ID:** NCT07742501
- **Lead sponsor:** University of Reading
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-11-01
- **Primary completion:** 2025-10-14
- **Final completion:** 2025-10-14
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2026-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07742501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07742501, "Genistein, Equol, Cognitive Function and Mood: Twelve-week. (GECFAMc)". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07742501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*